Figure 2From: Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospectsSchema for adoptive cellular therapy with genetically modified CAR T cells. T cells can be isolated from patient blood by apheresis, and genetically modified to express a transgene encoding a tumor-specific CAR. The genetically modified T cells are then expanded in vitro using several approaches before infusion into the patient.Back to article page